PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL EXPRESSION OF MGMT IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH TEMAZOLAMIDE

被引：0
|
作者：
Balasubramaniam, Anandh
Santosh, Vani
Arivazhagan, A.
Balaram, T.
Chandramouli, B. A.
Hegde, A. S.
Somasundaram, Kumaravel
Kondaiah, P.
Rao, M. R. S.
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [21] MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel
    Grossman, Rachel
    Burger, Peter
    Soudry, Ethan
    Tyler, Betty
    Chaichana, Kaisorn L.
    Weingart, Jon
    Olivi, Alessandro
    Gallia, Gary L.
    Sidransky, David
    Quinones-Hinojosa, Alfredo
    Ye, Xiaobu
    Brem, Henry
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (12) : 1938 - 1942
  • [22] MGMT immunohistochemical expression and promoter methylation in human glioblastoma
    Rodriguez, Fausto J.
    Thibodeau, Stephen N.
    Jenkins, Robert B.
    Schowalter, Karen V.
    Caron, Bolette L.
    O'Neill, Brian P.
    James, Charles David
    Passe, Sandra
    Slezak, Jeff
    Giannini, Caterina
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (01): : 59 - 65
  • [23] MEDIAN AND 2 YEARS SURVIVAL OF NEWLY DIAGNOSED UNMETHYLATED MGMT GLIOBLASTOMA PATIENTS TREATED WITH TEMFERON IMMUNO-GENE THERAPY
    Eoli, Marica
    Farina, Francesca
    Cuccarini, Valeria
    Gentner, Bernhard
    Barcella, Matteo
    Anghileri, Elena
    Bruzzone, Maria Grazia
    Carrabba, Matteo
    D'Alessandris, Quintino Giorgio
    Dimeco, Francesco
    Ferla, Valeria
    Franzin, Alberto
    Ferroli, Paolo
    Gagliardi, Filippo
    Legnani, Francesco
    Capotondo, Alessia
    Mazzoleni, Stefania
    Mortini, Pietro
    Olivi, Alessandro
    Pallini, Roberto
    Patane, Monica
    Paterra, Rosina
    Pollo, Bianca
    Saini, Marco
    Snider, Silvia
    Naldini, Luigi
    Russo, Carlo
    Ciceri, Fabio
    Finocchiaro, Gaetano
    NEURO-ONCOLOGY, 2024, 26
  • [24] PROGNOSTIC SIGNIFICANCE OF EXPRESSION OF MULTIDRUG RESISTANCE GENES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-CONTEINING THERAPHY
    Chernykh, Y.
    Golenkov, A.
    Vysotskaya, L.
    Belousov, K.
    HAEMATOLOGICA, 2016, 101 : 794 - 794
  • [25] Prognostic significance of sarcopenia in patients with newly diagnosed hepatocellular carcinoma
    Ha, Yeonjung
    Chon, Young Eun
    Lee, Yun Bin
    Kim, Mi Na
    Lee, Jooho
    Park, Hana
    Hwang, Seong Gyu
    Rim, Kyu Sung
    HEPATOLOGY, 2016, 64 : 665A - 665A
  • [26] Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study
    Caccese, Mario
    Simonelli, Matteo
    Villani, Veronica
    Rizzato, Simona
    Ius, Tamara
    Pasqualetti, Francesco
    Russo, Marco
    Ruda, Roberta
    Amoroso, Rosina
    Bellu, Luisa
    Bertorelle, Roberta
    Cavallin, Francesco
    Dipasquale, Angelo
    Carosi, Mariantonia
    Pizzolitto, Stefano
    Cesselli, Daniela
    Persico, Pasquale
    Casini, Beatrice
    Fassan, Matteo
    Zagonel, Vittorina
    Lombardi, Giuseppe
    CANCERS, 2022, 14 (10)
  • [27] Prognostic significance of syndromic classification in newly diagnosed epilepsy patients
    Del Felice, A.
    Ruffmann, C.
    Bogliun, G.
    Beghi, E.
    EPILEPSIA, 2006, 47 : 53 - 54
  • [28] MGMT methylation status may predict survival in elderly patients with newly diagnosed glioblastoma (GBM)
    Gerstner, E. R.
    Yip, S.
    Wang, D. L.
    Louis, D. N.
    Iafrate, A. J.
    Batchelor, T. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
    Christians, Arne
    Hartmann, Christian
    Benner, Axel
    Meyer, Jochen
    von Deimling, Andreas
    Weller, Michael
    Wick, Wolfgang
    Weiler, Markus
    PLOS ONE, 2012, 7 (03):
  • [30] PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER AND MISMATCH REPAIR SYSTEM IN NEWLY-DIAGNOSED AND RECURRENT MALIGNANT GLIOMAS
    Saito, K.
    Kobayashi, K.
    Shimizu, S.
    Suzuki, K.
    Shiokawa, Y.
    Nagane, M.
    NEURO-ONCOLOGY, 2017, 19 : 81 - 81
12345